Omron is undervalued by 31%, presenting a strong buy opportunity due to excessive market pessimism and resilient fundamentals in automation and healthcare. The company boasts leading positions in industrial automation and home healthcare, benefiting from secular trends like labor shortages, digital health, and sustainability. Despite recent revenue declines, Omron improved profitability through operational efficiency, maintains a healthy balance sheet, and consistently grows its dividend.